Riskpilot← Back to searchSign inGet full accessFARMATJENESTER AS
ASActiveOrg 914896142Sørflavegen 1, 2090 HurdalOther education n.e.c. · NACE 8559Est. 20150 employees
Revenue 2024
NOK 180K
+234% vs 2023
EBITDA margin
2.8%
+105% vs 2023
Equity ratio
80.9%
Financial strength
Net profit 2024
NOK 49K
+167% vs 2023
| Revenue | NOK 180K | +234% |
| EBITDA | NOK 5K | +105% |
| Net profit | NOK 49K | +167% |
| Total assets | NOK 1M | -14% |
| Equity | NOK 827K | -15% |
| Employees | 0 | — |
Legal name
FARMATJENESTER AS
Org number
914896142
Legal form
Aksjeselskap
NACE code
8559 · Other education n.e.c.
Founded
18. februar 2015
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Selskapets virksomhet er å drive med kurs, veiledning og konsulenttjenester innen farmasøytisk industri. I tillegg kan eier påta seg verv som farmasøytisk faglig ansvarlig (ffa) for grossist og kvalifisert person (qp) for tilvirkere etter godkjenning av statens legemiddelverk. Selskapet kan engasjere seg i annen virksomhet eller ved aksjekjøp.
Address
Sørflavegen 1, 2090 Hurdal
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 358 | 459 | 678 | 54 | 180 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 204 | 330 | 466 | −105 | 5 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 204 | 330 | 466 | −105 | 5 |
| Net financials | 12 | 9 | 12 | 31 | 38 |
| Profit before tax | 216 | 339 | 477 | −73 | 43 |
| Tax | 48 | 75 | 105 | −0 | −7 |
| Net profit | 168 | 264 | 372 | −73 | 49 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 564 | 1 632 | 1 629 | 1 187 | 1 022 |
| Equity | 1 064 | 1 329 | 1 251 | 978 | 827 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 500 | 303 | 378 | 209 | 195 |
| Total debt | 500 | 303 | 378 | 209 | 195 |
EBITDA margin
2.8%
This company
15.8%
Market median
-82% vs market
20202024
Equity ratio
80.9%
This company
38.2%
Market median
+112% vs market
20202024
Return on equity
6.0%
This company
18.4%
Market median
-67% vs market
20202024
Net profit margin
27.6%
This company
8.1%
Market median
+241% vs market
20202024
Asset turnover
0.18×
This company
1.12×
Market median
-84% vs market
20202024
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AS Chief Executive Officer | Chief Executive Officer | 2015 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2015 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FARMATJENESTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Audny Stenbråten | Chief Executive Officer | 0 companies |
| Arild Stenbråten | Chairman | 0 companies |